5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Lincoln Pharmaceuticals Ltd.

•
lincolnpharma.comBSE: 531633NSE: LINCOLN
Market Cap₹ 1,252 Cr.
Current Price
High / Low₹ 770 / 440
Stock P/E13.0
Book Value₹ 396
Price to Book1.64
Dividend Yield0.29 %
ROCE17.6 %
ROE13.0 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2014 • Pharma Products: 75.9% • Chemicals: 24.1%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 20.6%
  • Latest quarter profit grew 30.9% YoY, showing strong momentum
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record

CONS

  • Operating margins have contracted to 15.5% from 21.2%
  • Expensive relative to growth - PEG of 2.2

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.LINCOLN625.0512.981251.960.2936.2330.93177.2815.0717.5515.47
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
136156146142147161147168154163166187177
115125117124125133123141130138143162154
Operating Profit21313018232824272425242523
OPM %15.28%19.97%20.25%12.90%15.43%17.60%16.14%15.89%15.45%15.56%14.18%13.27%13.14%
8911710109-715715-424
Interest0000001000000
Depreciation3333333334444
Profit before Tax25373822293529163529351748
Tax %25.27%24.98%25.64%16.29%19.71%24.30%27.58%28.74%21.79%30.65%17.63%30.36%23.80%
Net Profit19282819242621122820291236
9.4913.8114.009.2811.8213.1510.375.7813.829.9814.285.8118.09

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
311304325353376423472510581623694
278262279293317336377421481522597
Operating Profit334246605987958910010197
OPM %10.46%13.94%14.14%17.09%15.79%20.58%20.22%17.47%17.21%16.29%13.99%
63671261022342242
Interest65442212121
Depreciation34455889111315
Profit before Tax30364358648496100122109128
Tax %27.65%23.33%24.00%19.79%22.61%25.60%27.70%27.43%23.67%24.58%24.52%
Net Profit2227334750626973938296
EPS0.000.000.000.000.0031.0034.6336.4046.5841.11—
Dividend Payout %7.50%8.76%9.16%6.43%6.05%4.83%4.33%4.12%3.86%4.38%—

COMPOUNDED SALES GROWTH

10 Years:
11%
5 Years:
11%
3 Years:
10%

COMPOUNDED PROFIT GROWTH

10 Years:
19%
5 Years:
11%
3 Years:
6%

STOCK PRICE CAGR

10 Years:
10%
5 Years:
9%
3 Years:
8%
1 Year:
12%

RETURN ON EQUITY

10 Years:
17%
5 Years:
16%
3 Years:
15%
Last Year:
13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 11

₹ 0.18

Rs.1.8000 per share(18%)Final Dividend

2025

Sep 12

₹ 0.18

Rs.1.8000 per share(18%)Final Dividend

2024

Sep 13

₹ 0.18

Rs.1.8000 per share(18%)Final Dividend

2023

Sep 15

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2022

Sep 15

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2021

Sep 16

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2018

Sep 19

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2017

Sep 21

₹ 0.12

Rs.1.2000 per share(12%)Dividend

2016

Sep 23

₹ 0.10

Rs.1.0000 per share(10%)Dividend

2015

Sep 23

₹ 0.10

Rs.1.0000 per share(10%)Dividend

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital16202020202020202020
115170200243284346413482573652
62586037957755
Trade Payables21253536425771517285
28272742577374765560
Total Liabilities242299341378412501585636725822
6368838891111132151179182
Capital Work in Progress37020216734
2036394660819791139174
25323629384773707779
00000000161166
Cash & Bank5587111318341322
126151174204212248249284152195
Total Assets242299341378412501585636725822

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
352730688589100696393
Cash from Investing-40-26-14-22-29-64-78-37-57-79
Cash from Financing118-4-30-38-6-3-5-5-6
-0-04-14-1-4-218

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
49.7849.7849.7849.7849.7849.7849.7849.7849.78
3.955.195.165.005.134.734.705.204.60
0.040.000.000.000.010.010.011.080.27
Government0.000.000.000.000.000.000.000.000.00
46.2445.0345.0645.2245.0745.4945.5243.9445.36

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-07
Copy of Newspaper Publication

2026-09-07 - Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for Notice of 32nd Annual General Meeting.

2026-09-05
Updates

2026-09-05 - Lincoln Pharmaceuticals Limited has informed the Exchange Intimation regarding dispatch of physical communication to the Shareholders who have not registered their email address. ''.

2026-09-05
Shareholders meeting

2026-09-05 - Lincoln Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026.

2026-08-29
Record Date

2026-08-29 - Lincoln Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Sep-2026.

2026-08-26
Copy of Newspaper Publication

2026-08-26 - Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication regarding the 32nd Annual General Meeting of the Company to be held on Wednesday, September 30, 2026.

2026-08-14
Copy of Newspaper Publication

2026-08-14 - Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-13
Outcome of Board Meeting

2026-08-13 - Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-06
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-06 - Lincoln Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-06-24
Trading Window

2026-06-24 - Lincoln Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

News

Recent coverage and analyst commentary for LINCOLN

Loading news…

🤖

AI Stock Analyst

Lincoln Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login